BS IS0 21474-2:2022 BSl Standards Publication In vitro diagnostic medical devices - Multiplex molecular testing for nucleic acids Part 2: Validation and verification bsi. BS ISO 21474-2:2022 BRITISH STANDARD National foreword This British Standard is the UK implementation of IS0 21474-2:2022 The UK participation in its preparation was entrusted to Technical Committee CH/212, IVDs. A list of organizations represented on this committee can be obtained on request to its committee manager. Contractual and legal considerations This publication has been prepared in good faith, however no representation, warranty, assurance or undertaking (express or implied) is or will be made, and no responsibility or liability is or will be accepted by BsI in relation to the adequacy, accuracy, completeness or reasonableness of this publication. All and any such responsibility and liability is expressly disclaimed to the full extent permitted by the law. This publication is provided as is, and is to be used at the recipient's own risk. The recipient is advised to consider seeking professional guidance with respect to its use of this publication. This publication is not intended to constitute a contract. Users are responsible for its correct application. @ The British Standards Institution 2022 Published by BSI Standards Limited 2022 ISBN9780539134018 ICS 11.100.10 Compliance with a British Standard cannot confer immunity from legal obligations. This British Standard was published under the authority of the Standards Policy and Strategy Committee on 31 May 2022. Amendments/corrigenda issued since publication Date Text affected BS IS0 21474-2:2022 INTERNATIONAL ISO STANDARD 21474-2 Firstedition 2022-05-16 In vitro diagnostic medical devices Multiplex molecular testing for nucleic acids Part 2: Validation and verification Dispositifs médicaux de diagnostic in vitro - Tests moleculaires multiplex pour les acides nucleiques - Partie 2: Validation et vérification Reference number ISO 21474-2:2022(E) ISO @ISO 2022